These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29072619)

  • 21. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis,
    Chaudhary M; Kumar N; Baldi A; Chandra R; Arockia Babu M; Madan J
    J Biomol Struct Dyn; 2020 Jan; 38(1):200-218. PubMed ID: 30784365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis.
    El-Azab AS; Abdel-Aziz AA; AlSaif NA; Alkahtani HM; Alanazi MM; Obaidullah AJ; Eskandrani RO; Alharbi A
    Bioorg Chem; 2020 Nov; 104():104345. PubMed ID: 33142413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Biological Evaluation and Molecular Docking Studies of 6-Aryl-2-Styrylquinazolin-4(3H)-Ones.
    Agbo EN; Makhafola TJ; Choong YS; Mphahlele MJ; Ramasami P
    Molecules; 2015 Dec; 21(1):E28. PubMed ID: 26712730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel 2,4-disubstituted quinazolines as cytotoxic agents and JAK2 inhibitors: Synthesis, in vitro evaluation and molecular dynamics studies.
    Jyothi Buggana S; Paturi MC; Perka H; Gade DR; Vvs RP
    Comput Biol Chem; 2019 Apr; 79():110-118. PubMed ID: 30785020
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Keshari AK; Singh AK; Raj V; Rai A; Trivedi P; Ghosh B; Kumar U; Rawat A; Kumar D; Saha S
    Drug Des Devel Ther; 2017; 11():1623-1642. PubMed ID: 28615927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel N-(3-ethynyl Phenyl)-6,7-bis(2-methoxyethoxy)Quinazoline-4-amine Derivatives: Synthesis, Characterization, Anti-cancer Activity,
    Dash A; Vaddamanu G; Karreddula R; Manubolu SSB; Kumari GP; Mulakayala N
    Anticancer Agents Med Chem; 2024; 24(7):514-532. PubMed ID: 38288814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
    Luo H; Yang S; Cai Y; Peng Z; Liu T
    Eur J Med Chem; 2014 Sep; 84():746-52. PubMed ID: 25064351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
    Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
    Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel morpholin-3-one fused quinazoline derivatives as EGFR tyrosine kinase inhibitors.
    Qin X; Lv Y; Liu P; Li Z; Hu L; Zeng C; Yang L
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1571-1575. PubMed ID: 26879314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study.
    Alqahtani AS; Ghorab MM; Nasr FA; Ahmed MZ; Al-Mishari AA; Attia SM
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
    Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
    Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
    Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and Synthesis of 4-substituted Quinazolines as Potent EGFR Inhibitors with Anti-breast Cancer Activity.
    Ahmed MF; Magdy N
    Anticancer Agents Med Chem; 2017; 17(6):832-838. PubMed ID: 27671305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, single crystal and antitumor activities of benzimidazole-quinazoline hybrids.
    Sharma A; Luxami V; Paul K
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3288-94. PubMed ID: 23611732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, antitumor evaluation and docking study of novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor (EGFR) inhibitors.
    Rao GW; Xu GJ; Wang J; Jiang XL; Li HB
    ChemMedChem; 2013 Jun; 8(6):928-33. PubMed ID: 23640754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, Biological Evaluation and Molecular Docking of Novel Indole-Aminoquinazoline Hybrids for Anticancer Properties.
    Mphahlele MJ; Mmonwa MM; Aro A; McGaw LJ; Choong YS
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
    Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
    Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies.
    Aly AA; El-Sheref EM; Bakheet MEM; Mourad MAE; Brown AB; Bräse S; Nieger M; Ibrahim MAA
    Bioorg Chem; 2018 Dec; 81():700-712. PubMed ID: 30268050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
    Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
    Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antiproliferative activity of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline.
    Cao SL; Han Y; Yuan CZ; Wang Y; Xiahou ZK; Liao J; Gao RT; Mao BB; Zhao BL; Li ZF; Xu X
    Eur J Med Chem; 2013 Jun; 64():401-9. PubMed ID: 23665106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.